Trial Use Samples — Clinical Evaluation Enquiries
Trial Use Samples — Clinical Evaluation Enquiries
Orthopedic surgical instrument trial-use samples require careful technical, regulatory and institutional review before any proposed clinical application. Hospitals, orthopedic surgeons, medical-device distributors and healthcare procurement teams must distinguish between nonclinical evaluation samples and medical devices that may lawfully be used in patient care.
ORTHOSURGI welcomes professional enquiries concerning orthopedic surgical instrument specifications, model availability, product documentation, evaluation requirements and potential clinical-use arrangements.
However, ORTHOSURGI does not offer an unrestricted surgical trial-use program through this page. Any potential clinical-use arrangement requires separate written review and appropriate authorization.
An engineering prototype, demonstration instrument or nonclinical evaluation sample must never be used in surgery merely because it has passed dimensional inspection or been supplied for technical assessment.
Before any proposed clinical use, the responsible parties must establish the device's intended purpose, applicable regulatory status, instructions for use, processing requirements, institutional authorization, liability arrangements and any necessary clinical investigation permissions.
This guide explains the differences between sample categories, required documentation, institutional responsibilities, clinical-use considerations and the appropriate enquiry process.
1. What Are Orthopedic Surgical Instrument Trial-Use Samples?
The expression trial-use sample may be used informally to describe an instrument supplied for evaluation. However, it does not identify a specific regulatory category or grant permission to use the instrument on a patient.
A proposed clinical-use arrangement involves a medical device that is intended to be used in patient care under appropriate legal and institutional conditions.
Such arrangements must be distinguished from technical purchasing evaluations, engineering studies, demonstrations and formal clinical investigations.
Common Sample Categories
Sample Category Purpose Patient Use
Engineering prototype Assess design, geometry and feasibility Not authorized by prototype status
Nonclinical evaluation sample Inspect dimensions, finish and operation without patient use Not permitted under the nonclinical evaluation arrangement
Demonstration instrument Support product presentation or technical discussion Not authorized by demonstration status
Market-authorized device proposed for clinical evaluation Assess a device within an appropriately authorized clinical-use arrangement Only after all applicable conditions are satisfied
Investigational device Support a properly authorized clinical investigation Only within the applicable investigation permissions and protocol
The sample's classification, labelling and permitted use must be established before it is transferred or evaluated.
An engineering or nonclinical sample must never be introduced into surgery without a separate lawful authorization process and appropriate documented clearance for the intended use.
2. ORTHOSURGI Trial Use Sample Enquiry Policy
ORTHOSURGI provides a technical enquiry pathway for qualified institutions interested in understanding whether particular orthopedic instruments may be considered for an appropriately reviewed clinical-use arrangement.
Submitting an enquiry does not establish that a clinical-use sample is available or authorized.
Key Conditions
• The exact instrument model and intended purpose must be identified.
• Product availability must be confirmed separately.
• The applicable regulatory status must be verified.
• Required technical and quality documentation must be reviewed.
• Labelling and instructions for use must correspond to the device.
• Reprocessing evidence must be assessed where applicable.
• Institutional responsibilities must be established.
• Any required clinical investigation permissions must be obtained.
• Written agreements must define relevant responsibilities and liabilities.
• The institution must authorize the proposed activity before patient use.
No clinical-use arrangement is established by a quotation request, product catalogue, sample shipment or informal communication.
3. Nonclinical Evaluation Versus Clinical Trial Use
Distinguishing sample categories is essential for safe and compliant procurement.
Nonclinical Technical Evaluation
Nonclinical evaluation may involve inspection of an instrument's dimensions, material, surface finish, jaw geometry, mechanism, packaging or other technical characteristics.
For example, a distributor may compare two Kerrison rongeur samples to assess footplate dimensions or inspect a bone-holding forceps model against an approved drawing.
These activities do not independently establish clinical performance, device conformity or authorization for patient use.
Clinical Evaluation of an Authorized Device
A qualified institution may wish to assess a legally marketed medical device within the bounds of its authorized intended purpose.
The institution must verify that the product is lawful for the relevant market and that the proposed arrangement satisfies applicable procurement, clinical governance, training, processing and liability requirements.
Formal Clinical Investigation
Some proposed studies or uses may constitute clinical investigations subject to additional regulatory, ethical and institutional requirements.
Whether these requirements apply must be established by qualified responsible parties.
The existence of an evaluation agreement alone does not authorize an investigational device to be used in patients.
4. Orthopedic Instruments That May Be Considered for Technical Enquiry
ORTHOSURGI welcomes product-specific enquiries across its orthopedic surgical instrument categories.
The following examples identify possible topics for documentation review, not confirmed clinical trial-use offerings.
Bone-Holding and Reduction Forceps
Technical enquiries may cover:
• Jaw patterns and geometry.
• Working lengths.
• Ratchet or locking mechanisms.
• Material specifications.
• Intended applications.
• Applicable instructions for use.
• Inspection and traceability requirements.
Related collection: Bone Reduction Instrument Set.
Kerrison Rongeurs
Kerrison rongeurs require model-specific evaluation of bite width, footplate design, cutting direction, shaft dimensions and operating mechanisms.
The nominal bite size does not establish equivalence between manufacturers.
Osteotomes, Chisels and Gouges
Evaluation may involve blade width, thickness, bevel geometry, handle configuration and material requirements.
Orthopedic Retractors and Bone Levers
Technical review should identify the precise retractor pattern, blade geometry, working length and manufacturer-defined intended purpose.
Drill Guides and Depth Gauges
These instruments require verified dimensional and interface compatibility.
A drill guide or depth gauge should not be assumed compatible with an implant system based on photographs or a general product description.
Orthopedic Instrument Sets
Related ORTHOSURGI collections include:
• Small Fragment Instrument Set
• Large Fragment Instrument Set
• Plate and Screw Preparation Set
• External Fixation Instrument Set
• Basic Spinal Instrument Set
• Instrument Set Sterilization Trays and Cases
For complete instrument sets, the exact bill of materials, sizes, system interfaces, tray configuration and individual component status must be evaluated.
None of these collection references confirms clinical-use sample availability.
5. Clinical Trial-Use Documentation Requirements
Qualified institutions should request and evaluate documentation appropriate to the exact product, proposed use and destination market.
Model-Specific Documentation Checklist
Document or Requirement Verification Purpose
Legal Manufacturer Identifies the responsible manufacturer
Device Model and SKU Confirms exact product identity
Intended Purpose Establishes manufacturer-defined use
Device Classification Supports regulatory pathway assessment
Market Authorization Verifies applicable lawful market status
Technical Specifications Confirms dimensions and configuration
Material Documentation Supports material requirements
Inspection Records Supports applicable quality assessment
Instructions for Use Defines approved handling and use conditions
Reprocessing Instructions Supports cleaning and sterilization review
Packaging and Labelling Identifies the supplied device and condition
Traceability Supports device and batch identification
Institutional Approval Records local authorization
Evaluation Agreement Defines permitted activities and responsibilities
Liability Arrangements Establishes contractual responsibilities
Investigation Permissions Applies where a regulated clinical investigation is proposed
A generic product certificate, supplier statement or catalogue entry cannot replace the relevant product-specific evidence.
6. Regulatory Verification Before Any Clinical Use
Medical-device requirements vary according to the intended country, device classification, manufacturer and proposed activity.
United States
For proposed use in the United States, the responsible institution and regulatory parties must assess applicable Food and Drug Administration requirements.
An investigational device exemption may be required for certain clinical investigations, and institutional review board requirements may also apply.
Other proposed uses may have different regulatory pathways.
FDA establishment registration and device listing must not be confused with FDA clearance or approval.
United Kingdom
For proposed clinical investigations in the United Kingdom, relevant MHRA and research ethics requirements must be evaluated.
The appropriate route depends on the device, its regulatory status, the purpose of the investigation and the relevant UK jurisdiction.
European Union
For the European Union, the applicable Medical Device Regulation requirements should be assessed, including relevant rules for clinical investigations where applicable.
Australia and Other Markets
The applicable medical-device regulator, market status, institutional requirements and investigation permissions should be evaluated for the destination market.
ORTHOSURGI does not claim that any listed instrument has the regulatory authorization necessary for a proposed clinical-use arrangement.
7. Institutional Authorization and Clinical Governance
A qualified clinical institution must establish its own requirements before permitting a new surgical instrument to be used in patient care.
Relevant responsibilities may involve:
• Clinical leadership.
• Hospital procurement.
• Medical-device management.
• Infection prevention and control.
• Sterile processing.
• Biomedical engineering.
• Risk management.
• Legal and contracts departments.
• Research governance where applicable.
The exact approval responsibilities depend on the institution and proposed activity.
Institutional review should be documented before the device is released for any approved use.
A surgeon's interest in evaluating an instrument does not, by itself, replace institutional or regulatory authorization.
8. Reprocessing Validation and Sterilization Requirements
Reusable orthopedic surgical instruments require appropriate manufacturer-supported reprocessing instructions.
Before considering any approved clinical use, the receiving institution should review whether it can process the device according to applicable validated instructions.
Reprocessing Documentation Checklist
• Manufacturer instructions for use.
• Point-of-use handling requirements.
• Cleaning and disinfection instructions.
• Disassembly instructions where applicable.
• Instrument inspection requirements.
• Maintenance instructions.
• Packaging requirements.
• Validated sterilization instructions.
• Applicable storage conditions.
• Reuse limitations and removal-from-service criteria.
Instruments with hinges, ratchets, internal mechanisms, detachable components or complex working ends may require additional processing considerations.
A statement such as "autoclavable" does not establish the adequacy of processing instructions.
No clinical-use sample should be released for surgery solely because an instrument appears clean or has undergone an unspecified sterilization cycle.
9. Sample Identification, Labelling and Traceability
Product identification is essential when an institution evaluates medical-device samples.
Every sample should be clearly linked to its applicable documentation.
Recommended Identification Information
• Manufacturer name.
• Model or SKU.
• Product description.
• Lot or serial identification where applicable.
• Drawing revision where relevant.
• Supplied condition.
• Intended evaluation category.
• Relevant restrictions on use.
• Associated documentation reference.
• Receiving institution.
• Authorized evaluation contact.
Labels must comply with applicable legal requirements.
Nonclinical or investigational instruments should not be presented as ordinary authorized clinical devices.
Tracking arrangements should support appropriate accountability, including return or disposition of samples where required.
10. Written Clinical Evaluation Agreements
Any potential clinical-use arrangement requires appropriate written terms.
The responsible institution and relevant parties should establish the permitted activities and associated responsibilities before proceeding.
Agreement Review Checklist
Agreement Area Information to Establish
Device Identification Exact instrument models
Intended Activity Defined clinical or investigational purpose
Regulatory Status Verified applicable evidence
Institutional Approval Required written authorizations
Device Ownership Ownership and custody arrangements
Sample Quantity Approved number of instruments
Processing Responsibility Cleaning, sterilization and handling
Training Applicable user training requirements
Liability Relevant contractual allocation
Incident Reporting Responsible contacts and procedures
Traceability Identification and tracking
Duration Agreed evaluation period
Return or Disposition Applicable end-of-evaluation procedure
Confidentiality Appropriate handling of records
The agreement must not override applicable medical-device laws, institutional requirements or patient-safety responsibilities.
11. Recommended Enquiry and Approval Workflow
ORTHOSURGI's proposed enquiry process separates preliminary technical review from any subsequent clinical-use authorization.
Stage 1: Submit an Institutional Enquiry
Provide the institution's name, country, professional contact, instrument model and proposed purpose.
Stage 2: Identify the Device
Confirm the exact model, intended use, manufacturing and regulatory information.
Stage 3: Determine the Evaluation Category
Establish whether the request concerns nonclinical technical inspection, a proposed lawful clinical-use arrangement or a formal clinical investigation.
Stage 4: Review Available Technical Documents
Assess available specifications, manufacturer records, instructions for use and reprocessing information.
Stage 5: Identify Regulatory and Institutional Requirements
The responsible parties determine which market authorizations, investigation permissions and institutional approvals are necessary.
Stage 6: Review Written Terms
Where appropriate, establish sample terms, permitted activities, custody, processing, liability, incident reporting and disposition responsibilities.
Stage 7: Document the Decision
Record whether the enquiry is declined, remains pending or has satisfied all relevant conditions for an explicitly defined arrangement.
Stage 8: Authorize Only the Agreed Activity
No instrument may be used beyond its lawful, approved and documented scope.
Submitting an enquiry, receiving a sample or completing this preliminary workflow does not guarantee approval for clinical use.
12. Trial Use Samples Versus Evaluation Samples
ORTHOSURGI's professional resources distinguish between two enquiry types.
Evaluation Samples
The Evaluation Samples resource concerns nonclinical purchasing and technical evaluation.
Typical activities may include:
• Visual inspection.
• Dimensional comparison.
• Material documentation review.
• Working-end geometry assessment.
• Nonclinical functional evaluation.
• Instrument-set configuration review.
• Sample acceptance against technical criteria.
These activities do not authorize use in surgery.
Trial Use Samples
The Trial Use Samples resource addresses preliminary enquiries concerning potential clinical-use arrangements.
Such enquiries require separate review of legal market status, applicable regulatory obligations, institutional permissions, processing and liability.
Where clinical-use requirements cannot be verified and satisfied, the proposed clinical-use arrangement must not proceed.
13. OEM and Prototype Development Considerations
OEM and private-label projects may involve new instrument dimensions, working-end geometries, materials or other design changes.
Such instruments may be evaluated in engineering and nonclinical settings.
However, prototype development does not independently establish suitability for patient use.
A change to a previously marketed design may also affect its regulatory status and require additional verification or other assessment.
ORTHOSURGI welcomes technical development enquiries, but any proposed clinical evaluation requires a separate determination of the applicable legal and institutional pathway.
Custom manufacturing feasibility, sample availability and technical documentation must be confirmed individually.
14. Questions Frequently Asked by Hospitals and Surgical Instrument Buyers
Does ORTHOSURGI offer unrestricted surgical trial-use samples?
No. ORTHOSURGI does not offer an unrestricted clinical trial-use program through this page.
Can an orthopedic surgeon request a sample for clinical evaluation?
A qualified institution may submit an enquiry. Any proposed clinical use requires separate regulatory, technical, institutional and contractual review.
Can an engineering prototype be used in surgery?
An engineering prototype is not authorized for surgery simply because it exists or has passed technical inspection. Any proposed patient use would require the appropriate lawful regulatory and institutional pathway.
Are nonclinical evaluation samples suitable for patient use?
No. Nonclinical evaluation samples must not be used in surgery under the nonclinical sample arrangement.
Does sample approval establish FDA clearance?
No. Technical sample evaluation does not establish FDA clearance, approval or an investigational device exemption.
Does ORTHOSURGI provide validated sterilization instructions?
The availability of appropriate reprocessing documentation must be verified for the exact product. No blanket reprocessing validation claim is made.
Can hospitals request orthopedic instrument-set samples?
Institutions may enquire about specific set configurations. Availability, the approved bill of materials, documentation and permitted evaluation activities require confirmation.
What is the difference between a clinical trial and a clinical product evaluation?
A formal clinical investigation may trigger specific regulatory and ethical requirements. A hospital's proposed evaluation of a legally marketed device may involve different requirements. The correct category must be determined from the actual activity, device and jurisdiction.
Can private-label instruments be evaluated clinically?
Any such proposal requires review of the device's legal manufacturer, intended use, product configuration, applicable regulatory status and institution-level requirements. Private-label branding does not establish authorization.
Does a sample agreement guarantee that an instrument can be used on a patient?
No. A commercial or evaluation agreement cannot substitute for applicable regulatory and institutional permissions.
15. Request an ORTHOSURGI Trial Use Sample Information Review
ORTHOSURGI welcomes preliminary enquiries from qualified hospitals, surgical institutions, medical-device procurement teams and authorized professional representatives.
To request information about a proposed orthopedic surgical instrument trial-use sample, please provide:
1. Institution or registered organization name.
2. Destination country.
3. Authorized professional contact.
4. Exact instrument model and SKU.
5. Manufacturer-defined intended purpose.
6. Proposed evaluation category.
7. Requested sample quantity.
8. Required technical documentation.
9. Applicable regulatory or institutional requirements already identified.
10. Preferred next steps for a preliminary documentation review.
Please do not submit patient medical records, patient identifiers or other sensitive personal information through a general enquiry form.
Contact ORTHOSURGI
Website: https://orthosurgi.com
Email: dentic.surgical@gmail.com
WhatsApp: +92 370 3302074
Suggested enquiry reference: Trial Use Samples — Institutional Documentation Review
For engineering inspection, supplier qualification or other nonclinical testing, use the separate Evaluation Samples enquiry pathway.
